A
Anne Stieber
Researcher at Heidelberg University
Publications - 26
Citations - 534
Anne Stieber is an academic researcher from Heidelberg University. The author has contributed to research in topics: Breast cancer & Medicine. The author has an hindex of 7, co-authored 13 publications receiving 355 citations.
Papers
More filters
Journal ArticleDOI
Prognosis of breast cancer molecular subtypes in routine clinical care: A large prospective cohort study
André Hennigs,Fabian Riedel,Adam Gondos,Peter Sinn,Peter Schirmacher,Frederik Marmé,Frederik Marmé,Dirk Jäger,Hans-Ulrich Kauczor,Anne Stieber,Katja Lindel,Jürgen Debus,Michael Golatta,Florian Schütz,Christof Sohn,Jörg Heil,Andreas Schneeweiss +16 more
TL;DR: Patients with a favorable subtype can expect an OS above 95 % and an LCR of almost 100 % over 5 years, while the outcome of patients with HER2 and Triple negative subtypes remains poor, thus necessitating more intensified research and care.
Journal ArticleDOI
Fast and Noninvasive Characterization of Suspicious Lesions Detected at Breast Cancer X-Ray Screening: Capability of Diffusion-weighted MR Imaging with MIPs.
Sebastian Bickelhaupt,Frederik Bernd Laun,Jana Tesdorff,Wolfgang Lederer,Heidi Daniel,Anne Stieber,Stefan Delorme,Heinz Peter Schlemmer +7 more
TL;DR: Unenhanced diagnostic MR imaging (DWIBS mammography), with an NPV of 0.92 and an acquisition time of less than 7 minutes, could help exclude malignancy in women with suspicious x-ray screening mammograms and has the potential to reduce unnecessary invasive procedures and emotional distress for breast cancer screening participants.
Journal ArticleDOI
Evaluation of Virtual Touch Tissue Imaging Quantification, a New Shear Wave Velocity Imaging Method, for Breast Lesion Assessment by Ultrasound
Michael Golatta,Mirjam Schweitzer-Martin,Aba Harcos,Sarah Schott,Christina Gomez,Anne Stieber,Geraldine Rauch,Christoph Domschke,Joachim Rom,Florian Schütz,Christof Sohn,Jörg Heil +11 more
TL;DR: There is a significant difference regarding the mean maximum velocity of benign and malignant lesions and the combination of BIRADS and VTIQ led to improved test validity.
Book
Prognosis of breast cancer molecular subtypes in routine clinical care
André Hennigs,Fabian Riedel,Adam Gondos,Peter Sinn,Peter Schirmacher,Frederik Marmé,Dirk Jäger,Hans-Ulrich Kauczor,Anne Stieber,Katja Lindel,Jürgen Debus,Michael Golatta +11 more
TL;DR: In this article, the authors evaluated up-to-date oncological outcome of breast cancer molecular subtypes in routine clinical care of a specialized BCU and calculated estimates for local control rate (LCR), disease free survival (DFS), distant disease-free survival (DDFS) and relative overall survival (ROS).
Journal ArticleDOI
Can a pathological complete response of breast cancer after neoadjuvant chemotherapy be diagnosed by minimal invasive biopsy
Joerg Heil,Benedikt Schaefgen,Peter Sinn,Hannah Richter,Aba Harcos,Christina Gomez,Anne Stieber,André Hennigs,Geraldine Rauch,Florian Schuetz,Christof Sohn,Andreas Schneeweiss,Michael Golatta +12 more
TL;DR: A VAB can accurately diagnose a pCR, given a histopathologically representative sample, according to the histopathological evaluation.